Cargando…

Mitochondria and Mitochondrial Cascades in Alzheimer’s Disease

Decades of research indicate mitochondria from Alzheimer’s disease (AD) patients differ from those of non-AD individuals. Initial studies revealed structural differences, and subsequent studies showed functional deficits. Observations of structure and function changes prompted investigators to consi...

Descripción completa

Detalles Bibliográficos
Autor principal:	Swerdlow, Russell H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869994/ https://www.ncbi.nlm.nih.gov/pubmed/29036828 http://dx.doi.org/10.3233/JAD-170585

Ejemplares similares

Mitochondrial Dysfunction and Stress Responses in Alzheimer’s Disease
por: Weidling, Ian, et al.
Publicado: (2019)

Mitochondrial links between brain aging and Alzheimer’s disease
por: Wilkins, Heather M., et al.
Publicado: (2021)

Pathogenesis of Alzheimer’s disease
por: Swerdlow, Russell H
Publicado: (2007)

Mitochondrial Manipulation and the Quest for Alzheimer's Treatments
por: Swerdlow, Russell H.
Publicado: (2015)

Mitochondria and Parkinson's Disease
por: Simon, David K., et al.
Publicado: (2011)

Mitochondria and Alzheimer’s Disease: the Role of Mitochondrial Genetic Variation
por: Ridge, Perry G., et al.
Publicado: (2018)

Mitochondrial Haplotypes Associated with Biomarkers for Alzheimer’s Disease
por: Ridge, Perry G., et al.
Publicado: (2013)

Disentangling Mitochondria in Alzheimer’s Disease
por: Johri, Ashu
Publicado: (2021)

Mitochondrial Medicine and the Neurodegenerative Mitochondriopathies
por: Swerdlow, Russell H.
Publicado: (2009)

Opposing Effects of ApoE2 and ApoE4 on Glycolytic Metabolism in Neuronal Aging Supports a Warburg Neuroprotective Cascade against Alzheimer’s Disease
por: Zhang, Xin, et al.
Publicado: (2023)

Mitochondria, Amyloid β, and Alzheimer's Disease
por: Readnower, Ryan D., et al.
Publicado: (2011)

Mitochondria, Cognitive Impairment, and Alzheimer's Disease
por: Mancuso, M., et al.
Publicado: (2009)

Dietary Neuroketotherapeutics for Alzheimer’s Disease: An Evidence Update and the Potential Role for Diet Quality
por: Taylor, Matthew K., et al.
Publicado: (2019)

Sweet Mitochondria: A Shortcut to Alzheimer’s Disease
por: Moreira, Paula I.
Publicado: (2018)

Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances
por: Wang, Wenzhang, et al.
Publicado: (2020)

Therapeutic Potential of Targeting Mitochondria for Alzheimer’s Disease Treatment
por: Atlante, Anna, et al.
Publicado: (2022)

Maternal transmission of Alzheimer's disease: Prodromal metabolic phenotype and the search for genes
por: Mosconi, Lisa, et al.
Publicado: (2010)

Mitochondria-Targeted Antioxidant SS31 Prevents Amyloid Beta-Induced Mitochondrial Abnormalities and Synaptic Degeneration in Alzheimer’s Disease
por: Calkins, Marcus J., et al.
Publicado: (2012)

Mitochondria and the eye—manifestations of mitochondrial diseases and their management
por: Chen, Benson S., et al.
Publicado: (2023)

Anti-Amyloid Therapies for Alzheimer’s Disease and the Amyloid Cascade Hypothesis
por: Fedele, Ernesto
Publicado: (2023)

Mitochondria, Diabetes, and Alzheimer’s Disease
por: Milone, Margherita
Publicado: (2012)

Mitochondria on the move: Horizontal mitochondrial transfer in disease and health
por: Dong, Lan-Feng, et al.
Publicado: (2023)

Mitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's Diseases
por: Fernández-Moriano, Carlos, et al.
Publicado: (2015)

Mitochondria-Derived Damage-Associated Molecular Patterns in Neurodegeneration
por: Wilkins, Heather M., et al.
Publicado: (2017)

Molecular Dysfunctions of Mitochondria-Associated Membranes (MAMs) in Alzheimer’s Disease
por: Eysert, Fanny, et al.
Publicado: (2020)

Editorial of special column on Drug targets and drug development for Alzheimer's disease
por: Ding, Wen-Xing, et al.
Publicado: (2022)

A Search for Mitochondrial Damage in Alzheimer’s Disease Using Isolated Rat Brain Mitochondria
por: Faizi, Mehrdad, et al.
Publicado: (2016)

Alzheimer's Disease and the Amyloid Cascade Hypothesis: A Critical Review
por: Reitz, Christiane
Publicado: (2012)

Pyroglutamate Aβ cascade as drug target in Alzheimer’s disease
por: Bayer, Thomas A.
Publicado: (2021)

Inflammatory Cascade in Alzheimer’s Disease Pathogenesis: A Review of Experimental Findings
por: de Oliveira, Jade, et al.
Publicado: (2021)

The Oxygen Cascade from Atmosphere to Mitochondria as a Tool to Understand the (Mal)adaptation to Hypoxia
por: Samaja, Michele, et al.
Publicado: (2023)

Cell type and sex specific mitochondrial phenotypes in iPSC derived models of Alzheimer’s disease
por: Flannagan, Kaitlin, et al.
Publicado: (2023)

Human mitochondrial transcriptional factor A breaks the mitochondria-mediated vicious cycle in Alzheimer’s disease
por: Oka, Sugako, et al.
Publicado: (2016)

Mitochondrial Drugs for Alzheimer Disease
por: Bonda, David J., et al.
Publicado: (2009)

Advances in the pathogenesis of Alzheimer’s disease: a re-evaluation of amyloid cascade hypothesis
por: Dong, Suzhen, et al.
Publicado: (2012)

New Insights into lncRNAs in Aβ Cascade Hypothesis of Alzheimer’s Disease
por: Hao, Yitong, et al.
Publicado: (2022)

The Amyloid Cascade Hypothesis in Alzheimer’s Disease: Should We Change Our Thinking?
por: Kurkinen, Markku, et al.
Publicado: (2023)

Mitochondria in Huntington’s disease: implications in pathogenesis and mitochondrial-targeted therapeutic strategies
por: Jurcau, Anamaria, et al.
Publicado: (2022)

Systemic Metabolism and Mitochondria in the Mechanism of Alzheimer’s Disease: Finding Potential Therapeutic Targets
por: Song, Meiying, et al.
Publicado: (2023)

Mitochondria and Oxidative Stress as a Link between Alzheimer’s Disease and Diabetes Mellitus
por: Veselov, Ivan M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fnjeb83pcg9am1m6e0tpa3nfhc